Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Payables and Accruals [Abstract] | ||
| Compensation expense | $ 9,716 | $ 8,315 |
| Clinical trial research and development services | 5,335 | 1,236 |
| Manufacturing and other research and development services | 3,774 | 2,255 |
| General and administrative services | 393 | 342 |
| Other | 80 | 40 |
| Accrued and other current liabilities | $ 19,298 | $ 12,188 |
| X | ||||||||||
- Definition Accrued general and administrative services current. No definition available.
|
| X | ||||||||||
- Definition Accrued liabilities and other liabilities current. No definition available.
|
| X | ||||||||||
- Definition Clinical Trial Research and Development Services No definition available.
|
| X | ||||||||||
- Definition Manufacturing and Other Research and Development Services No definition available.
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|